Literature DB >> 19834973

Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis.

Jacob Tveiten Bjerrum1, Morten Hansen, Jørgen Olsen, Ole Haagen Nielsen.   

Abstract

BACKGROUND: Genome-wide gene expression (GWGE) profiles of mucosal colonic biopsies have suggested the existence of a continuous inflammatory state in quiescent ulcerative colitis (UC). The aim of this study was to use DNA microarray-based GWGE profiling of mucosal colonic biopsies and isolated colonocytes from UC patients and controls in order to identify the cell types responsible for the continuous inflammatory state.
METHODS: Adjacent mucosal colonic biopsies were obtained endoscopically from the descending colon in patients with active UC (n = 8), quiescent UC (n = 9), and with irritable bowel syndrome (controls, n = 10). After isolation of colonocytes and subsequent extraction of total RNA, GWGE data were acquired using Human Genome U133 Plus 2.0 GeneChip Array (Affymetrix, Santa Clara, CA). Data analysis was carried out by principal component analysis and projection to latent structure-discriminant analysis using the SIMCA-P 11 software (Umetrics, Umeå, Sweden).
RESULTS: A clear separation between active UC, quiescent UC, and control biopsies were found, whereas the model for the colonocytes was unable to distinguish between quiescent UC and controls. The differentiation between quiescent UC and control biopsies was governed by unique profiles containing gene expressions with significant fold changes. These primarily belonged to the family of homeostatic chemokines, revealing a plausible explanation for the abnormal regulated innate immune response seen in patients with UC.
CONCLUSIONS: This study has demonstrated the presence of a continuous inflammatory state in quiescent UC, which seems to reflect an altered gene expression profile of lamina propria cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19834973     DOI: 10.1002/ibd.21142

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  20 in total

1.  miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.

Authors:  Mehmet Coskun; Jacob Tveiten Bjerrum; Jakob Benedict Seidelin; Jesper Thorvald Troelsen; Jørgen Olsen; Ole Haagen Nielsen
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

2.  CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.

Authors:  Maria Lampinen; Amanda Waddell; Richard Ahrens; Marie Carlson; Simon P Hogan
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

3.  A Seven-NF-κB-Related Gene Signature May Distinguish Patients with Ulcerative Colitis-Associated Colorectal Carcinoma.

Authors:  Chao-Yi Ge; Li-Yuan Wei; Yu Tian; Hua-Hong Wang
Journal:  Pharmgenomics Pers Med       Date:  2020-12-02

4.  Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative colitis.

Authors:  Tao Yang; Xiao Ma; Ruilin Wang; Honghong Liu; Shizhang Wei; Manyi Jing; Haotian Li; Yanling Zhao
Journal:  Saudi Pharm J       Date:  2022-04-01       Impact factor: 4.562

5.  Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo.

Authors:  Chang Sup Lee; Kristen K Penberthy; Karen M Wheeler; Ignacio J Juncadella; Peter Vandenabeele; Jeffrey J Lysiak; Kodi S Ravichandran
Journal:  Immunity       Date:  2016-03-29       Impact factor: 31.745

6.  Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis.

Authors:  Jodie Ouahed; William Gordon; James B Canavan; Huanyu Zhou; Sarah Du; David von Schack; Kathleen Phillips; Lu Wang; W Augustine Dunn; Michael Field; Shelby Friel; Alexandra Griffith; Spencer Evans; Sophia Tollefson; Madeline Carrellas; Bonnie Cao; Ami Merker; Athos Bousvaros; Dror S Shouval; Kenneth Hung; Christopher Lepsy; Lovisa Afzelius; Joshua R Korzenik; Scott B Snapper
Journal:  Inflamm Bowel Dis       Date:  2018-11-29       Impact factor: 5.325

7.  Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse.

Authors:  J-H La; G F Gebhart
Journal:  Neurogastroenterol Motil       Date:  2014-10-13       Impact factor: 3.598

8.  Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.

Authors:  Jacob Tveiten Bjerrum; Yulan Wang; Fuhua Hao; Mehmet Coskun; Christian Ludwig; Ulrich Günther; Ole Haagen Nielsen
Journal:  Metabolomics       Date:  2014-06-01       Impact factor: 4.290

9.  Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.

Authors:  Atle van Beelen Granlund; Arnar Flatberg; Ann E Østvik; Ignat Drozdov; Bjørn I Gustafsson; Mark Kidd; Vidar Beisvag; Sverre H Torp; Helge L Waldum; Tom Christian Martinsen; Jan Kristian Damås; Terje Espevik; Arne K Sandvik
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis.

Authors:  Jacob Tveiten Bjerrum; Mattias Rantalainen; Yulan Wang; Jørgen Olsen; Ole Haagen Nielsen
Journal:  Metabolomics       Date:  2013-08-21       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.